Loading...
Eldepryl, Zelapar, Emsam
Antiparkinson • MAO-B inhibitor
Half-life
10 hours (metabolites 18-25 hours)
Protein Binding
85%
Metabolized By
CYP2B6, CYP2C19, CYP3A4
External
Drugs.comSelectively inhibits MAO-B, increasing dopamine availability in striatum
Drug Class
Antiparkinson
Subclass
MAO-B inhibitor
Half-life
10 hours (metabolites 18-25 hours)
Time for plasma concentration to decrease by 50%
Protein Binding
85%
Fraction bound to plasma proteins
Therapeutic Index
Wide
Margin between therapeutic and toxic doses